BRAFV600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells

被引:37
作者
Sueda, Toshinori [1 ,2 ]
Sakai, Daisuke [1 ]
Kawamoto, Koichi [2 ]
Konno, Masamitsu [1 ]
Nishida, Naohiro [1 ]
Koseki, Jun [3 ]
Colvin, Hugh [1 ,2 ,3 ]
Takahashi, Hidekazu [2 ]
Haraguchi, Naotsugu [2 ]
Nishimura, Junichi [2 ]
Hata, Taishi [2 ]
Takemasa, Ichiro [2 ]
Mizushima, Tsunekazu [2 ]
Yamamoto, Hirofumi [4 ]
Satoh, Taroh [1 ]
Doki, Yuichiro [1 ,2 ,3 ]
Mori, Masaki [1 ,2 ,3 ]
Ishii, Hideshi [1 ,3 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gastrointestinal Surg, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Dept Canc Profiling Discovery, Suita, Osaka 5650871, Japan
[4] Osaka Univ, Grad Sch Med & Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
ENERGY SENSOR; BRAF; PHOSPHORYLATION; RESISTANCE; PATHWAY; NUTRIENT; GROWTH; TARGET; LKB1;
D O I
10.1038/srep18949
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although BRAF(V600E) mutation is associated with adverse clinical outcomes in patients with colorectal cancer (CRC), response and resistance mechanisms for therapeutic BRAF(V600E) inhibitors remains poorly understood. In the present study, we demonstrate that selective BRAF(V600E) inhibition activates AMP-activated protein kinase (AMPK), which induces autophagy as a mechanism of therapeutic resistance in human cancers. The present data show AMPK-dependent cytoprotective roles of autophagy under conditions of therapeutic BRAF(V600E) inhibition, and AMPK was negatively correlated with BRAF(V600E) dependent activation of MEK-ERK-RSK signaling and positively correlated with unc-51-like kinase 1 (ULK1), a key initiator of autophagy. Furthermore, selective BRAF(V600E) inhibition and concomitant suppression of autophagy led to the induction of apoptosis. Taken together, present experiments indicate that AMPK plays a role in the survival of BRAF(V600E) CRC cells by selective inhibition and suggest that the control of autophagy contributes to overcome the chemoresistance of BRAF(V600E) CRC cells.
引用
收藏
页数:14
相关论文
共 32 条
[1]   Principles and Current Strategies for Targeting Autophagy for Cancer Treatment [J].
Amaravadi, Ravi K. ;
Lippincott-Schwartz, Jennifer ;
Yin, Xiao-Ming ;
Weiss, William A. ;
Takebe, Naoko ;
Timmer, William ;
DiPaola, Robert S. ;
Lotze, Michael T. ;
White, Eileen .
CLINICAL CANCER RESEARCH, 2011, 17 (04) :654-666
[2]   eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies [J].
Boussemart, Lise ;
Malka-Mahieu, Helene ;
Girault, Isabelle ;
Allard, Delphine ;
Hemmingsson, Oskar ;
Tomasic, Gorana ;
Thomas, Marina ;
Basmadjian, Christine ;
Ribeiro, Nigel ;
Thuaud, Frederic ;
Mateus, Christina ;
Routier, Emilie ;
Kamsu-Kom, Nyam ;
Agoussi, Sandrine ;
Eggermont, Alexander M. ;
Desaubry, Laurent ;
Robert, Caroline ;
Vagner, Stephan .
NATURE, 2014, 513 (7516) :105-+
[3]   Autophagy is a therapeutic target in anticancer drug resistance [J].
Chen, Suning ;
Rehman, Sumaiyah K. ;
Zhang, Wei ;
Wen, Aidong ;
Yao, Libo ;
Zhang, Jian .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1806 (02) :220-229
[4]   GENERALIZED EQUATIONS FOR THE ANALYSIS OF INHIBITIONS OF MICHAELIS-MENTEN AND HIGHER-ORDER KINETIC SYSTEMS WITH 2 OR MORE MUTUALLY EXCLUSIVE AND NON-EXCLUSIVE INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 115 (01) :207-216
[5]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[6]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[7]   Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy [J].
Egan, Daniel F. ;
Shackelford, David B. ;
Mihaylova, Maria M. ;
Gelino, Sara ;
Kohnz, Rebecca A. ;
Mair, William ;
Vasquez, Debbie S. ;
Joshi, Aashish ;
Gwinn, Dana M. ;
Taylor, Rebecca ;
Asara, John M. ;
Fitzpatrick, James ;
Dillin, Andrew ;
Viollet, Benoit ;
Kundu, Mondira ;
Hansen, Malene ;
Shaw, Reuben J. .
SCIENCE, 2011, 331 (6016) :456-461
[8]   Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E [J].
Esteve-Puig, Rosaura ;
Canals, Francesc ;
Colome, Nuria ;
Merlino, Glenn ;
Angel Recio, Juan .
PLOS ONE, 2009, 4 (03)
[9]   Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819
[10]   ULK1•ATG13•FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy [J].
Ganley, Ian G. ;
Lam, Du H. ;
Wang, Junru ;
Ding, Xiaojun ;
Chen, She ;
Jiang, Xuejun .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18) :12297-12305